Zdrowie i gospodarka · 24/06/2020
FDA Clears Dextrose Injectable for Sale Without Safety or Effectiveness Concerns
The US Food and Drug Administration (FDA) has determined that certain dextrose injectable products, including 30g/100mL, 40g/100mL, 60g/100mL, and 70g/100mL, can remain on the market without safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs).